Upload your draft for a confidential readiness check before you submit. See the likely reviewer risk, top blocker, and journal-fit signal in about 1-2 minutes. No payment needed for the preview.
“It’s the only AI assistant I’ve tried that reviews the full manuscript, not just the abstract. With ChatGPT there’s often a kind of confirmation bias that’s much less present in Manusights.”
Free scan in about 1-2 minutes.
Free preview. Full report $29, only if you want it.
×ManusightsConfidential AI path
Anthropic Privacy Partner. Zero-retention manuscript processing. Your manuscript is not used for training.
What the free preview shows
Submission-risk verdict
See whether this draft looks safe to submit or still too risky.
Top blockers with direct quotes
See the issues most likely to trigger editor or reviewer pushback.
Optional journal-fit signal
Add a target journal for a more specific fit and reviewer-risk read.
Inspect the paid report first
Nature Communications sample diagnostic
See the actual report format before you upload. Judge the paid output on substance, not promises.
Journal fit
Borderline for Nature Comms
Top issue
Translational framing is too weak
What you get
Prioritized revision path and journal call
Why people are running this earlier
The review is more valuable now because the failure modes are changing: stronger editor triage, more overclaimed AI-assisted drafts, weaker journal targeting, and less patience for manuscripts whose scientific story is not clearly supported on first read.
Detection reality
What editors can catch, what detectors still miss, and why reference problems usually matter more than style classifiers.
Publisher workflow
A practical read on where publishers are moving and what that changes for authors before they submit.
Security risk
A direct explanation of prompt injection risk and why naive manuscript-review tools are easier to manipulate than they look.
Category standard
The checklist serious authors should use when deciding whether an AI review product is safe enough for a high-stakes submission.
How scoring works
The preview is built to judge the science first, then the journal bar, then the reviewer risk. Technical trust checks still matter, but they are not supposed to drown out the main submission decision.
Core Science & Contribution
Emphasis: Primary
Claim Support
Emphasis: Primary
Reviewer Risk
Emphasis: Secondary
Journal Fit
Emphasis: Secondary
Technical Trust Checks
Emphasis: Background
85-100
Strong
70-84
Promising
55-69
Needs Work
0-54
High Risk
Why generic AI is not enough
A general-purpose chatbot can sound fluent about a manuscript. It cannot reliably act like a serious pre-submission screen.
Each run uses a live literature search across five academic databases, so the papers most likely to matter in review are part of the actual assessment.
Citations are checked against trusted scholarly sources before they appear in the report. If we cannot verify the paper exists, it does not get cited.
The system is tuned for long manuscripts, figures, methods, and journal-specific reviewer risk rather than generic conversational output.
Reviewer-built rubric
The rubric was built with scientists who actively review for Cell, Nature, and Science, using real peer-review patterns rather than generic academic prose.
Novelty gap analysis
Incremental versus meaningful advance
Figure-level scrutiny
What breaks reviewer confidence
Mechanistic sufficiency
When claims need more evidence
Translational framing
What top-tier positioning requires
Sample output
A six-section .docx with verified citations, section scores, and a prioritized fix list.
Pre-Submission Assessment
Nature Communications
03 · Journal Fit
Current target (NC, IF 15.7): Borderline. The mechanistic data is solid but translational framing is underdeveloped.
04 · Key Experiments
Priority A: In vivo validation required...
Shown for format. Your report is calibrated to your chosen journal. The issues, journal path, and revision order will reflect your manuscript and target.
Need the full sample? Use the sample-report link near the upload form so the preview flow stays the main next step.
Real output from delivered reports
Not vague manuscript hygiene advice. Every issue is supposed to connect the scientific blocker to the revision move it unlocks.
The central efficacy claim is leaning on subgroup patterns rather than the strongest prespecified signal, which weakens the main translational story for a top clinical audience.
Rebuild the headline claim around the prespecified endpoint or add a stronger justification for why the subgroup result deserves to carry the paper. Otherwise the paper reads more exploratory than definitive.
Introduction does not distinguish your findings from Chen et al. (2023, Nat. Commun.), which reported a closely related mechanism in the same cell type.
Add a paragraph directly addressing how your data extends, contradicts, or contextualizes the 2023 Chen study. Editors at this tier read the literature. Unexplained overlap reads as a red flag.
Mechanistic depth is solid but the translational framing is underdeveloped for a Nature Medicine audience. The clinical implication is a single paragraph in Section 5.
Expand to 3-4 sentences covering patient population, therapeutic window, and the nearest analogous approved drug class. This is standard at journals with IF above 40.
Three steps
Drop your PDF or DOCX manuscript, choose a target journal, and start the Free Readiness Scan.
Get a manuscript-specific readiness view: top blockers, direct quotes, desk-reject risk, and journal realism in about 1-2 minutes.
Get the Full AI Diagnostic with reference checks, figure-level feedback, journal-fit guidance, and a prioritized fix plan delivered as a .docx in about 30 minutes.
Free preview for everyone. Two paid tiers when you want more.
For one manuscript.
Reviewer-style critique of every section, with concrete fixes.
Free preview includes top concerns from a partial read. Pay only when you want the full review.
What researchers say
It caught that we were missing in vivo validation for our main claim. Obvious in hindsight but three of us missed it. Had two weeks before the Nature Medicine submission window closed so we actually had time to fix it. Worth way more than $29.
Anqing C.
Postdoc, Immunology
Medical school (US)
Submitted to Nature Medicine
Flagged a confounding variable in our causal inference framing that I genuinely thought was fine. Ran the additional analysis before submitting to Nat Comms. Reviewers raised the same issue, saw it was already addressed, minor revisions. I got lucky that I checked.
Miguel T.
PI, Computational Biology
Research institute (EU)
Submitted to Nature Communications
Found three papers from the last year that I completely missed, all directly relevant to our novelty claim, and I would've submitted without citing any of them. Added a paragraph addressing the overlap and the reviewer who flagged those same papers said we'd handled it well. Could've easily been a reject.
Sojung K.
PhD student, Neuroscience
University (Canada)
Submitted to Sci. Transl. Med.
Free preview first
Full AI Diagnostic
Available after the free preview. Typical delivery in ~30 minutes.
Free preview first. No account. No subscription. One-time.
60-day money-back guarantee
Email us within 60 days of purchase for a no-questions-asked refund.
Expert Review
3-7 business days
Intended use and limitations
A six-section .docx report delivered to your inbox. Each section is scored 1-5, with an overall recommendation and a prioritized A/B/C list of what to fix first. Every issue comes with a specific fix, a rationale, and verified citations from recent literature. You can see a real example by clicking "Get the sample report" above.
Free Readiness Scan in about 1-2 minutes. Full AI Diagnostic delivery is typically around 30 minutes. Runs 24/7, including weekends and holidays.
Yes. Your manuscript file is encrypted in transit and permanently deleted after analysis. It's never stored, never shared, and never used to train any model.
That's actually the best time. Most researchers use the report to decide on a target journal, close figure gaps, and tighten methods before they consider the paper final. Getting feedback while you can still act on it is the whole point.
Biomedical and life sciences broadly: oncology, immunology, neuroscience, cardiology, metabolism, infectious disease, cell biology, and more. We cover 40+ journals across tiers, from Nature and Cell down to field-specific journals. If your target isn't on the list, email team@manusights.com and we'll confirm before you pay.
Three things. It searches 500M+ live papers (ChatGPT's knowledge has a cutoff). Every citation is verified against CrossRef and PubMed (ChatGPT invents them). And the scoring rubric was built with CNS peer reviewers using their actual review documents, not just published papers.
Different product. The expert review pairs you with a scientist who actively reviews for journals in your field. They write 12-18 specific recommendations with a cover letter strategy. Most researchers run the AI diagnostic first to catch fixable issues, then decide if they need deeper feedback for a top-tier submission.
Yes. Each submission is priced separately. Some researchers run it, revise, then run it again to confirm the issues were addressed before final submission.
60-day money-back guarantee. Email us within 60 days of purchase for a no-questions-asked refund. No forms, no waiting.
Your reviewers will find these issues. The question is whether you find them first.
Free preview first. Full report available in ~30 minutes if you want it.
Upload PDF. See the free preview first. Upgrade only if you want the full report.
No account needed. One-time. No subscription. Ever.